Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

OVID

Ovid Therapeutics Inc

Apr 28 • 04:00PM ET

2.70

+0.01 0.37 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: PTCT FOLD RARE SRPT CRSP EDIT NTLA BLUE QURE SGMO

| Held by: VTI VXF SURI BSVO PRFZ QQQS DFAS AVSC IBRN

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.26	Insider Own	11.24%	Shs Outstand	173.04M	Perf Week	-5.26%
Market Cap	467.20M	Forward P/E	-	EPS next Y	-0.59	Insider Trans	-0.10%	Shs Float	153.59M	Perf Month	17.39%
Enterprise Value	410.98M	PEG	-	EPS next Q	-0.12	Inst Own	38.79%	Short Float	4.53%	Perf Quarter	49.17%
Income	-17.41M	P/S	64.44	EPS this Y	-113.94%	Inst Trans	9.60%	Short Ratio	2.26	Perf Half Y	65.64%
Sales	7.25M	P/B	2.69	EPS next Y	-19.48%	ROA	-14.33%	Short Interest	6.96M	Perf YTD	65.64%
Book/sh	1.00	P/C	6.71	EPS next 5Y	-	ROE	-17.51%	52W High	3.11 -13.04%	Perf Year	671.43%
Cash/sh	0.40	P/FCF	-	EPS past 3/5Y	32.53% 29.81%	ROIC	-12.21%	52W Low	0.27 899.63%	Perf 3Y	-24.58%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	68.99% -10.48%	Gross Margin	95.86%	Volatility	6.25% 7.84%	Perf 5Y	-31.30%
Dividend TTM	-	EV/Sales	56.69	EPS Y/Y TTM	29.56%	Oper. Margin	-585.20%	ATR (14)	0.19	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	8.97	Sales Y/Y TTM	1181.27%	Profit Margin	-240.11%	RSI (14)	56.05	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	8.97	EPS Q/Q	190.79%	SMA20	1.96%	Beta	0.15	Target Price	5.25
Payout	-	Debt/Eq	0.10	Sales Q/Q	844.74%	SMA50	21.36%	Rel Volume	0.48	Prev Close	2.69
Employees	23	LT Debt/Eq	0.09	Earnings	Mar 18 BMO	SMA200	73.75%	Avg Volume	3.08M	Price	2.70
IPO	May 05, 2017	Option/Short	Yes / Yes	EPS/Sales Surpr.	151.24% 816.99%	Trades		Volume	1,482,024	Change	0.37%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)